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It is estimated that more than 50 million cattle are infected with Mycobacterium bovis worldwide, resulting
in severe economic losses. Current diagnosis of tuberculosis (TB) in cattle relies on tuberculin skin testing, and
when combined with the slaughter of test-positive animals, it has significantly reduced the incidence of bovine
TB. The failure to eradicate bovine TB in Great Britain has been attributed in part to a reservoir of the
infection in badgers (Meles meles). Accurate and reliable diagnosis of infection is the cornerstone of TB control.
Bacteriological diagnosis has these characteristics, but only with samples collected postmortem. Unlike
significant wild animal reservoirs ofM. bovis that are considered pests in other countries, such as the brushtail
possum (Trichosurus vulpecula) in New Zealand, the badger and its sett are protected under United Kingdom
legislation (The Protection of Badgers Act 1992). Therefore, an accurate in vitro test for badgers is needed
urgently to determine the extent of the reservoir of infection cheaply and without destroying badgers. For cattle,
a rapid on-farm test to complement the existing tests (the skin test and gamma interferon assay) would be
highly desirable. To this end, we have investigated the potential of an electronic nose (EN) to diagnose infection
of cattle or badgers with M. bovis, using a serum sample. Samples were obtained from both experimentally
infected badgers and cattle, as well as naturally infected badgers. Without exception, the EN was able to
discriminate infected animals from controls as early as 3 weeks after infection with M. bovis, the earliest time
point examined postchallenge. The EN approach described here is a straightforward alternative to conven-
tional methods of TB diagnosis, and it offers considerable potential as a sensitive, rapid, and cost-effective
means of diagnosing M. bovis infection in cattle and badgers.
Accurate and reliable diagnosis of infection with members of
the Mycobacterium tuberculosis complex is the cornerstone of
tuberculosis (TB) control, whether in humans, cattle, or other
species. It is estimated that, worldwide, there are more than 50
million cattle infected with Mycobacterium bovis, resulting in
economic losses of approximately $3 billion annually (49). Cur-
rent diagnosis of TB in cattle relies on tuberculin skin testing,
the detection of a delayed-type hypersensitivity reaction to the
intradermal inoculation of tuberculin. An enzyme-linked im-
munosorbent assay for detecting the release of gamma inter-
feron in whole blood stimulated with tuberculin was developed
in the early 1990s (47) and is now being used in some countries
(such as New Zealand and the Republic of Ireland) as an
ancillary test in particular situations, e.g., for herds with severe
or chronic outbreaks of bovine TB. Combined with the slaugh-
ter of test-positive animals and control of the movement of
cattle, the skin test has been instrumental in eradicating TB
from some countries (e.g., Australia) and in reducing the in-
cidence of bovine TB in many others. However, in situations in
which there is a wildlife reservoir of infection, such as with
badgers in Great Britain and the Republic of Ireland and with
brushtail possums in New Zealand, this strategy has failed to
eradicate the disease. Indeed, in Great Britain over the last two
decades, there has been a dramatic rise in the incidence of TB
in cattle (28).
Accurate diagnosis of M. bovis infection in badgers can be
achieved by bacteriological examination but only for postmor-
tem samples. Therefore, accurate in vitro diagnosis is required
to allow disease surveillance of the badger population, as well
as to underpin any possible future policies to control TB in
badgers, for example, by vaccination. However, the best of the
antibody assays for TB in badgers is only 62% sensitive (27),
whereas in vitro cellular assays are better but impractical for
routine use (8). In addition, a rapid on-farm test for cattle,
complementing existing tests, could be beneficial.
Against this background, we have investigated the potential
of an “electronic nose” (EN) to diagnose infection of cattle or
badgers with M. bovis by using a serum sample. Smell can be
used to diagnose diseases and has been used by both the
Greeks and the Chinese since 2000 BC (reviewed in references
41 and 54). Electronic nose is the colloquial name for an
instrument made up of chemical sensors combined with a pat-
tern recognition system (18). The key function of an EN is to
mimic the human olfactory system. In the EN, the human
olfactory receptors have their analogues in chemical sensors
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that produce an electrical signal (similar to nerve cells). These
signals are subsequently analyzed by pattern recognition soft-
ware. The pattern recognition software corresponds to the
cerebral cortex of the brain and is able to classify and memo-
rize odors (3, 42, 43).
The most commonly used types of sensors in ENs are metal
oxide sensors (10, 45), conducting polymers (17, 23), and pi-
ezoelectric-based sensors, such as bulk acoustic wave sensors
or surface acoustic wave sensors (7, 9). The sensors are char-
acterized by a partial specificity, i.e., they respond to a certain
group of chemicals, such as alcohols and aldehydes, etc., rather
than a single compound (18). This partial specificity generates
a unique signature (pattern) of the sample. All types of sensors
share a common basic principle: the interaction of volatile
compounds with the sensor surface leads to a change of phys-
ical properties (conductivity, resistance, and frequency) of the
sensor, which is measured.
The EN has been applied in several areas to characterize the
odors of products such as wine (11), beer (44), and paper (25).
More recently, ENs have been used for the quality control and
process monitoring of foodstuffs such as olive oil (20, 21) and
milk (32). However, the potential of the EN as a diagnostic
tool is attracting an increasing number of research groups for
the diagnosis of infectious diseases such as bacterial vaginosis
(6) and pulmonary (29) and urinary tract infections (1, 39), as
well as breath analyses of patients suffering from diabetes (53),
uremia (30), or lung cancer (12). Recently, the approach was
used to diagnose the causative organism of diarrhea by sniffing
stools (46), demonstrating the versatility of the approach. The
present study demonstrates that EN technology can also be
used for the diagnosis of TB in both cattle and badgers and is
the first report of the application of EN sensing to serum.
MATERIALS AND METHODS
Animals and serum samples. Sera from badgers (Meles meles) were obtained
from three sources. In the first case, badgers were experimentally infected with
M. bovis via the endobronchial route at three different doses: 10, 100, and 3,000
CFU. These doses were chosen to generate a lung infection that would mimic
that seen in naturally infected badgers. Three badgers were used for each dose,
and an additional three unchallenged animals were used as controls. Blood was
obtained from each animal 3 weeks prior to challenge, immediately prior to
challenge, and at three weekly intervals after challenge for 15 weeks.
In the second case, 12 badgers were experimentally infected with 10,000 CFU
of M. bovis via the endobronchial route. This dose was chosen to provide a
reproducible pattern of disease in all inoculated badgers. An additional four
unchallenged animals served as controls. Three experimentally infected badgers
were euthanized at 6, 12, and 18 weeks after infection for other purposes, with
the remaining badgers being euthanized at week 24. Blood was obtained from
each animal 3 weeks prior to challenge, immediately prior to challenge, and at
three weekly intervals after challenge for the duration of the experiment.
All badgers recruited for the experimental studies originated from locations in
the Republic of Ireland where the badger population was known to be free of TB.
The badgers were housed in a facility divided into enclosures equipped with
artificial setts. After experimental infection, all badgers were confirmed to be
positive for M. bovis infection by culture from tissue samples postmortem. Un-
infected control animals were similarly confirmed to be culture negative. Full
details of the experimental challenge studies will be submitted for publication
elsewhere.
The final sources of badger sera were 19 animals that had been killed as part
of the Department of Environment Food and Rural Affairs/Independent Scien-
tific Group Randomised Badger Culling Trial (13). Each badger was subjected to
routine postmortem examination and culture for the presence of M. bovis. Sera
were chosen for study from 10 culture-confirmed tuberculous badgers and 9
culture-negative badgers.
Cattle sera were obtained from animals experimentally infected with M. bovis.
Eight calves (4- to 5-month-old female Holstein-Friesians) were infected with an
M. bovis field strain from Great Britain (AF 2122/97) by endobronchial instilla-
tion of 4 104 or 6 104 CFU as described previously (52). Blood samples were
collected from all animals 3, 5, 8, and 15 weeks after challenge and from six of
the calves at 24 weeks. Animals were skin tested with the single intradermal
comparative cervical tuberculin test 14 weeks after M. bovis infection. Two
animals were slaughtered at 16 weeks postinfection, and the remaining six were
slaughtered at 24 weeks. Disease was confirmed in all animals by the presence of
gross pathology (visible lesions in the lungs and associated lymph nodes, as well
as in the lymph nodes of the head region) typical for bovine TB and by the
culture of M. bovis from tissue samples collected postmortem. Control sera (27
in total) were obtained from the same animals prior to challenge, as well as from
19 other uninfected animals fed the same diet and housed in an equivalent
manner for up to 6 weeks.
All sera used for this study were stored frozen at 20°C until they were used
for testing.
Sample preparation. The frozen serum samples were defrosted on ice to
minimize the loss of volatile compounds. The serum samples (100 l) were
diluted (1:4) in 0.9% (wt/vol) NaCl solution and thoroughly mixed. The mixture
was transferred into a 5-ml headspace vial (Macherey and Nagel, Loughborough,
Leicestershire, United Kingdom) and immediately sealed with a crimp cap with
a silicon-Teflon septum (Jaytee Bioscience Ltd., Whitstable, Kent, United King-
dom). The sealed headspace vials were subsequently incubated for 45 min at
37°C.
Gas-sensing system and headspace sampling. For this study, an electronic
nose (model BH-114; Bloodhound Sensors, Leeds, United Kingdom) which
employs 14 conducting polymers based on polyaniline was used. The sensor unit
automatically set two calibration points. The first one was the baseline, which was
obtained when activated carbon-filtered (carbon cap 150; Whatman) air was
passed over the sensor at a flow rate of 4 ml min1. The second calibration point
was a reference point obtained from the headspace of a control sample vial
containing distilled water.
The interaction of the volatile compounds and the conducting polymer surface
produced a change in electrical resistance, which was measured and subsequently
displayed on a computer screen. Two sensor parameters were selected to study
the sensor response: divergence (maximum step response) and area (area under
the response curve). The sampling profile was set at 10 s of absorption and 15 s
of desorption.
For the analysis of the headspace from test samples, the sample vials were
connected to the electronic nose by inserting a needle into the headspace of the
sample vials. The gas from the headspace was passed over the sensor surface at
a flow rate of 200 ml min1, which was automatically set by the sensor unit. A
time delay of 2 min was set between each measurement.
Data analysis. The multivariate data set was analyzed with an Excel add-in
program (XLstat, version 3.4; XLstat, Paris, France). The data were analyzed by
using principal component analysis (PCA) and linear discriminant function anal-
ysis (DFA). The identities of the serum samples (experiment, treatment group,
and/or the time when the serum was collected) were disclosed to enable the PCA
and DFA models to be constructed. However, in order to cross-validate the DFA
model, a proportion of serum samples was withheld from building the model.
The data from each withheld sample were then inserted into the discriminant
functions of the completed model, and each withheld sample was subsequently
assigned to the class for which its centroid has the smallest Euclidean distance to
the unknown sample (38). This method provided a test of the accuracy of the
DFA model.
(i) Principal component analysis. PCA is an unsupervised data reduction
procedure. The procedure aims to describe the variation in a multivariate data
set in terms of a set of uncorrelated variables, each of which is a particular linear
combination of the original variables. In other words, the original data matrix is
projected from a highly dimensional space into a less dimensional space, pref-
erably of two or three dimensions. During the process, the original data set is
reduced, i.e., compressed, with as little loss of information as possible. This
outcome is achieved by filtering out the noise in the original data matrix without
removing essential information described in the variance of the data (35, 38).
Mathematically, PCA aims to decompose the original i  j data matrix X into
its i  k score matrix T, its k  j loading matrix P, and the residual matrix E
according to the following formula: X  TP  E, where i is the number of
samples, j is the number of variables, and k is the number of principal compo-
nents (PCs). The PCs are determined on the basis of the maximum variance
criterion. Each subsequent PC describes a maximum of variance which is not
modeled by the previous one. According to this formula, the first PC contains
most of the variance of the data (15, 38). The relationship between samples can
be visualized by plotting the scores (PCs) against each other.
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(ii) Discriminant function analysis. Discriminant function analysis is a super-
vised classification procedure aimed at formalizing a decision boundary between
different classes (38). The decision boundary is calculated so that the variance
between different classes is maximized and the variance within individual classes
is minimized (38). Different ways to calculate the decision boundary exist. In a
multivariate data set, this action is done by solving an eigenvalue problem. The
eigenvector (w) with the greatest eigenvalue () provides the first discriminant
function (s1). The second discriminant function (s2) is calculated from the ei-
genvector with the second-greatest eigenvalue. This procedure is continued until
all discriminant functions are found to solve the discrimination problem (38).
The original data set is visualized by plotting the individual discriminant func-
tions against each other.
RESULTS
Analysis of sera from badgers infected with three different
doses of M. bovis. Sera from experimentally infected and con-
trol badgers were used to determine whether the EN could
discriminate infected animals from uninfected animals over the
course of infection. Figure 1 shows the PCA and DFA analyses
of the raw data obtained with the EN. It was possible to dis-
criminate between control (uninfected) and infected samples
by using the first two principal components (PC1 and PC2),
which accounted for 82% of the variance (information) of the
original data matrix. Furthermore, the sera from the infected
badgers could be grouped into three further clusters coincident
with the dose of M. bovis used to establish the infection (Fig.
1A), irrespective of the time between infection and collection
of the serum sample. Based on the principal components, a
discrimination model was built. As can be seen in Fig. 1B, only
the first two discriminant functions were necessary to solve the
discrimination problem. The DFA model was validated by the
analysis of 15 withheld (“unknown”) samples. All unknown
samples were classified correctly as being either control or
infected. Furthermore, all unknown infected samples were cor-
rectly assigned to one of the three subclusters according to the
infection dose.
FIG. 1. PCA (A) and DFA (B) analyses of sera from badgers experimentally infected with three different doses of M. bovis (filled triangles)
or from uninfected controls (filled squares). Blood was obtained from each animal 3 weeks prior to challenge, immediately prior to challenge, and
at three weekly intervals after challenge for 15 weeks. For cross-validation, 15 samples were withheld from the building of the DFA model but were
subsequently assigned correctly once the model was built (open squares, control sera; open triangles, infected sera). PC 1, principal component
1; PC 2, principal component 2; S1, discriminant function 1; S2, discriminant function 2. Numbers in parentheses indicate the percentages of the
data matrix described by the relevant components and functions. The dashed lines were added by the authors.
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Analysis of sera from badgers over a time course of M. bovis
infection. Next, the EN was used to analyze sera that were
from badgers experimentally infected with a single dose of M.
bovis but obtained over the course of infection. The raw EN
data were analyzed by PCA (data not shown) and DFA (Fig.
2). As for the previous experiment, it was possible to discrim-
inate between samples obtained from uninfected and infected
badgers. Within the infected group, four subclusters could be
identified. These four subclusters represented different time
points after infection, namely, 3, 6, 9, and 12 to 24 weeks
postinfection (Fig. 2). The discrimination model was validated
against 17 unknown samples, all of which were correctly clas-
sified as being from either control or infected animals. Fur-
thermore, all unknown infected samples were correctly as-
signed to one of the four subclusters according to the time after
infection. It was not possible to distinguish between samples
taken 12 or more weeks after infection.
Analysis of naturally infected badgers. In case the results
obtained from experimentally infected badgers were peculiar
to the means of infection, sera were tested from badgers nat-
urally infected with M. bovis. The raw EN data were analyzed
by PCA (data not shown) and DFA (Fig. 3). As for the exper-
imentally infected badgers, it was possible to discriminate be-
tween infected and uninfected badgers. As might be expected
from a more varied sample of animals, the variations within the
two groups were bigger than that seen with the experimentally
infected badger samples. The DFA model was validated by
cross-validation with six samples. All six unknown samples
(three from each group) were correctly classified as either
uninfected or infected.
Infected calves. Based on the results obtained with badger
sera, we extended the investigation to cattle sera. Application
of the EN allowed the discrimination of infected cattle from
control (uninfected) animals as early as 3 weeks after infection
(Fig. 4). Four subclusters were identified within the infected
cluster, representing different time points over the course of
infection. Sera obtained 15 or more weeks after infection clus-
tered together (Fig. 4). The DFA model was validated by
cross-validation with 16 samples. All 16 unknown samples (half
from the control group) were correctly classified as either un-
infected or infected. Furthermore, the eight unknown infected
samples were correctly assigned to one of the four subclusters
according to the time after infection.
DISCUSSION
In 1923, Omelianski was one of the first to study and review
the odor naturally liberated by microorganisms, among them
M. tuberculosis (37). Since then, a number of techniques have
been used to formally characterize the odors associated with
pathogenic microorganisms or disease (reviewed in references
41 and 54). Using an EN to measure the volatile compounds
produced from plate cultures, Gibson et al. classified 12 dif-
ferent bacteria and 1 pathogenic yeast with 93.4% accuracy
(19). Recently, Pavlou et al. have demonstrated proof of prin-
ciple that an EN can be used to detect volatiles in M. tubercu-
losis-infected human sputum liberated by 2 to 6 h of enzymatic
lipase treatment (40, 41). We have extended these observations
by using untreated serum and demonstrate that an EN can be
used to differentiate badgers and cows with TB from unin-
fected animals. Strikingly, infections in badgers and cattle
could be diagnosed as early as 3 weeks after experimental
infection, which was the earliest time point examined.
PCA and DFA are two classical multivariate methods used
to analyze EN data. The DFA model describes the probability
that an unknown sample belongs to the class of closest simi-
larity. For most unknown samples in this study, this probability
was between 0.65 and 0.70. For the routine diagnosis of TB in
FIG. 2. DFA analysis of badger sera obtained at three weekly intervals after experimental infection with 10,000 CFU of M. bovis (filled
triangles) for 24 weeks. Uninfected control sera (filled squares) were obtained at the same time points from a group of uninfected badgers and
include sera from all animals, taken 3 weeks prior to challenge and immediately prior to challenge. For cross-validation, 17 samples were withheld
from the building of the DFA model but were subsequently assigned correctly once the model was built (open squares, control sera; open triangles,
infected sera). S1, discriminant function 1; S2, discriminant function 2. Numbers in parentheses indicate the percentages of the data matrix
described by the relevant functions. The dashed line was added by the authors.
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cattle and badgers, it would be preferable to build a DFA
model on a larger sample size, thereby giving a higher certainty
of infection status, although it is likely that more appropriate
analytical methods (such as neural networks) would be adopt-
ed at that stage. Notwithstanding the smaller sample size used
in this study, the DFA model still classified all unknown sam-
ples (38 from badgers and 16 from cattle) correctly. At present,
we do not know if the EN would discriminate M. bovis infection
from other diseases that may be present in the individual, but
it is likely that the naturally infected badgers would have har-
bored other infectious organisms, such as leptospires, coccidia,
or enterococci (24, 33, 36). Nearly all the experimentally in-
fected badgers, as well as the unchallenged badgers used in this
study, had lungworm infection with associated pathology, which
did not confound the analysis. However, the EN should be
evaluated in situations of known infection, especially in the
case of cattle infection with Mycobacterium avium subsp.
paratuberculosis and other infections causing appreciable
lung and other tissue pathologies, such as Mycoplasma bovis,
Haemophilus somnus (Histophilus somni), and Pasteurella
(Mannheimia) haemolytica (22, 51). It will also be important to
establish whether BCG vaccination will influence the outcome
of EN testing in either cattle or badgers.
The PCA analyses indicated that there was enough informa-
FIG. 3. DFA analysis of sera from wild badgers with culture-confirmed TB (filled triangles) or badgers TB negative by culture and postmortem
analysis (filled squares). Blood was obtained from each animal antemortem. For cross-validation, six samples were withheld from the building of
the DFA model but were subsequently assigned correctly once the model was built (open squares, control sera; open triangles, infected sera). S1,
discriminant function 1; S2, discriminant function 2. Numbers in parentheses indicate the percentages of the data matrix described by the relevant
functions. The dashed line was added by the authors.
FIG. 4. DFA analysis of cattle sera obtained at the times indicated after experimental infection with M. bovis (filled triangles). Uninfected
control sera (filled squares) were obtained from the same animals prior to challenge and include sera from other uninfected animals fed the same
diet and housed in an equivalent manner for up to 6 weeks. For cross-validation, eight samples were withheld from the building of the DFA model
but were subsequently assigned correctly once the model was built (open squares, control sera; open triangles, infected sera). S1, discriminant
function 1; S2, discriminant function 2. Numbers in parentheses indicates the percentages of the data matrix described by the relevant functions.
The dashed line was added by the authors.
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tion present in the samples to allow discrimination between the
infectious dose and time after infection, as well as between
infected animals and controls. The EN could therefore be
detecting increasing concentrations of volatile components re-
sulting from increased bacterial loads and/or the host response
to infection. We have consistently been unable to culture viable
M. bovis from the blood of experimentally infected cattle or
badgers, so it is unlikely the EN is detecting the presence of the
bacterium itself. However, the observation that mycobacterial
antigens can be detected in the serum of humans infected with
M. tuberculosis and wildlife infected with M. bovis (2, 4, 34, 48,
50) suggests the EN may be detecting compounds released
from the bacteria into the circulation during infection, e.g.,
fatty acids, esters, or lactones (16). Candidates for volatile host
components could include molecules involved in the immune
response or those that increase in concentration with increas-
ing tissue pathology. There are numerous candidates for such
components, including superoxide dismutase (5), mucins (26),
and hepatocyte growth factor/scatter factor (31). At this stage,
it is not possible to determine precisely which volatiles are
responsible for the sensor response.
With the urgent need to develop more sensitive, rapid, and
cost-effective means of diagnosing M. bovis infection in cattle
and badgers, the EN approach described here offers consider-
able potential. The method is not only easy to perform, and
therefore does not require a specifically trained technician, but
is also cost- and time-effective, since, once validated, it would
dispense with the need for the isolation of M. bovis by culture
(which is protracted and costly) or repeated visits to the farm
(in the case of the cattle skin test). Furthermore, the technol-
ogy is amenable to automation and/or condensation into a
portable device that could eventually permit the rapid testing
of large numbers of animals in situ (14).
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